Clinical Trials Directory

Trials / Sponsors / Nordic Lymphoma Group

Nordic Lymphoma Group

Network · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingCtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)
Primary Central Nervous System (CNS) Lymphoma
—2025-01-01
Active Not RecruitingAcalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
MCL, Mantle Cell Lymphoma
Phase 22021-12-15
RecruitingA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab
DLBCL, Diffuse Large B Cell Lymphoma
Phase 32020-08-19
UnknownVenetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Relapsed Non Hodgkin Lymphoma
Phase 1 / Phase 22018-07-01
Active Not RecruitingBiomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis
Lymphoma, Large B-Cell, Diffuse
Phase 22017-08-04
CompletedTrial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Phase 22017-07-07
CompletedCHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
Primary Disease
Phase 22011-03-01
CompletedDose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)
Diffuse Large B-Cell Lymphoma
Phase 22004-11-01